189 related articles for article (PubMed ID: 23683571)
1. Predictive value of elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Akgul O; Uyarel H; Ergelen M; Pusuroglu H; Gul M; Turen S; Bulut U; Baycan OF; Ozal E; Cetin M; Yıldırım A; Uslu N
J Crit Care; 2013 Oct; 28(5):882.e13-20. PubMed ID: 23683571
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of elevated D-dimer in patients undergoing primary angioplasty for ST elevation myocardial infarction.
Akgul O; Uyarel H; Pusuroglu H; Gul M; Isiksacan N; Turen S; Erturk M; Surgit O; Cetin M; Bulut U; Baycan OF; Uslu N
Blood Coagul Fibrinolysis; 2013 Oct; 24(7):704-10. PubMed ID: 23571687
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.
Pusuroglu H; Akgul O; Erturk M; Uyarel H; Bulut U; Akkaya E; Buturak A; Surgit O; Fuat A; Cetin M; Yldrm A
Coron Artery Dis; 2014 Nov; 25(7):558-64. PubMed ID: 25004238
[TBL] [Abstract][Full Text] [Related]
4. The relationship between γ-glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gul M; Uyarel H; Ergelen M; Ekmekci A; Ozal E; Murat A; Kul S; Celik O; Karaca G; Akturk F; Eksik A
Coron Artery Dis; 2013 Jun; 24(4):272-8. PubMed ID: 23542158
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Akgul O; Baycan OF; Bulut U; Somuncu MU; Pusuroglu H; Ozyilmaz S; Gul M; Demir AR; Yılmaz E; Yazan S; Kokturk U; Cetin I; Uyarel H
Coron Artery Dis; 2015 Nov; 26(7):592-7. PubMed ID: 26061437
[TBL] [Abstract][Full Text] [Related]
6. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
Kaya MG; Akpek M; Lam YY; Yarlioglues M; Celik T; Gunebakmaz O; Duran M; Ulucan S; Keser A; Oguzhan A; Gibson MC
Int J Cardiol; 2013 Sep; 168(2):1154-9. PubMed ID: 23219132
[TBL] [Abstract][Full Text] [Related]
8. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction.
Silva D; Cortez-Dias N; Jorge C; Marques JS; Carrilho-Ferreira P; Magalhães A; Martins SR; Gonçalves S; da Silva PC; Fiúza M; Diogo AN; Pinto FJ
Am J Cardiol; 2012 May; 109(10):1431-8. PubMed ID: 22356795
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.
Gul M; Uyarel H; Ergelen M; Akgul O; Karaca G; Turen S; Ugur M; Ertürk M; Kul S; Surgit O; Bozbay M; Uslu N
Am J Cardiol; 2013 Jan; 111(2):166-71. PubMed ID: 23102877
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
Manzano-Fernández S; López-Cuenca A; Januzzi JL; Parra-Pallares S; Mateo-Martínez A; Sánchez-Martínez M; Pérez-Berbel P; Orenes-Piñero E; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Marín F
Am J Cardiol; 2012 Nov; 110(9):1240-8. PubMed ID: 22818840
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of elevated neutrophil to lymphocyte ratio in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.
Ergelen M; Uyarel H; Altay S; Kul Ş; Ayhan E; Isık T; Kemaloğlu T; Gül M; Sönmez O; Erdoğan E; Turfan M
Clin Appl Thromb Hemost; 2014 May; 20(4):427-32. PubMed ID: 23314674
[TBL] [Abstract][Full Text] [Related]
13. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Sen N; Afsar B; Ozcan F; Buyukkaya E; Isleyen A; Akcay AB; Yuzgecer H; Kurt M; Karakas MF; Basar N; Hajro E; Kanbay M
Atherosclerosis; 2013 May; 228(1):203-10. PubMed ID: 23489347
[TBL] [Abstract][Full Text] [Related]
14. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Zhao L; Wang L; Zhang Y
J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of red blood cell transfusion in patients undergoing primary angioplasty for ST elevation myocardial infarction.
Ergelen M; Uyarel H; Altay S; Ayhan E; Isik T; Bacaksiz A; Kemaloğlu T; Gül M; Cicek G; Kul S; Ertas G; Tasal A
Coron Artery Dis; 2012 Dec; 23(8):517-22. PubMed ID: 23013926
[TBL] [Abstract][Full Text] [Related]
16. The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Bolińska S; Sobkowicz B; Zaniewska J; Chlebińska I; Boliński J; Milewski R; Tycińska A; Musiał W
Kardiol Pol; 2011; 69(1):33-9. PubMed ID: 21267962
[TBL] [Abstract][Full Text] [Related]
17. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Ariza-Solé A; Sánchez-Elvira G; Sánchez-Salado JC; Lorente-Tordera V; Salazar-Mendiguchía J; Sánchez-Prieto R; Romaguera-Torres R; Ferreiro-Gutiérrez JL; Gómez-Hospital JA; Cequier-Fillat A
Thromb Res; 2013; 132(6):652-8. PubMed ID: 24112751
[TBL] [Abstract][Full Text] [Related]
18. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
[TBL] [Abstract][Full Text] [Related]
19. The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.
Bench TJ; Parikh PB; Jeremias A; Brener SJ; Naidu SS; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
J Invasive Cardiol; 2013 Apr; 25(4):166-9. PubMed ID: 23549488
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
